AstraZeneca PLC (AZN) NASDAQ

77.60

+0.0434(+0.06%)

Updated at September 17 03:19PM

Currency In USD

Valuation

Market Cap203.11B
Enterprise Value227.74B
P/E Ratio28.53
PEG Ratio3.91
Price/Sales Ratio4.21
Price/Book Ratio5.39
Enterprise/Revenue4.66
Enterprise/EBITDA14.17

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.15
Operating Margin0.21

Management Effectiveness

Return On Assets0.08
Return On Equity0.2

Income Statement

Revenue54.07B
Revenue/Share36.97
Gross Profit43.87B
EBITDA15.44B
Net Income7.04B
Diluted EPS2.25

Balance Sheet

Total Cash7.11B
Total Cash/Share4.59
Total Debt32.84B
Total Debt/Equity0.73
Current Ratio0.86
Book Value Per Share28.97

Price History

52-Week Change-1.18
52-Week High82.41
52-Week Low61.24
Moving Average 50 Days76.07
Moving Average 200 Days71.85

Statistics

Average Volume4.33M
Shares Outstanding3.1B
% Held by Institutions31.98

Dividend And Splits

Trailing Annual Dividend Rate2.1
Trailing Annual Dividend Yield1.35
Payout Ratio0.58
Last Split Factor2:1
Last Split DateJuly 27, 2015